Chemosensitisation By, and Single Agent Activity of, ATR Inhibitor VE-821 in Human Breast Cancer Cells

被引：0
|
作者：
Middleton, F. K. [1 ]
Chen, T. [1 ]
Pollard, J. R. [2 ]
Curtin, N. J. [1 ]
机构：
[1] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Vertex Pharmaceut, Oxford, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72076-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
278
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [41] Characteristics of apoptosis induction in human breast cancer cells treated with a ceramidase inhibitor
    Izgordu, Huseyin
    Sezer, Canan Vejselova
    Comlekci, Emre
    Kutlu, Hatice Mehtap
    CYTOTECHNOLOGY, 2020, 72 (06) : 907 - 919
  • [42] Characteristics of apoptosis induction in human breast cancer cells treated with a ceramidase inhibitor
    Hüseyin İzgördü
    Canan Vejselova Sezer
    Emre Çömlekçi
    Hatice Mehtap Kutlu
    Cytotechnology, 2020, 72 : 907 - 919
  • [43] The Anti-Cancer Activity of Astragaloside on Human Breast Cancer Cells In Vitro
    Zhao, Su-ying
    Teng, Feng-meng
    Li, Peng-fei
    Gao, Feng
    Wu, Qian
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (10): : 2037 - 2041
  • [44] The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells
    Tong, WG
    Ding, XZ
    Adrian, TE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) : 942 - 948
  • [45] Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
    Madhavi Billam
    Michele D. Sobolewski
    Nancy E. Davidson
    Breast Cancer Research and Treatment, 2010, 120 : 581 - 592
  • [46] Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
    Denoyelle, C
    Albanese, P
    Uzan, G
    Hong, L
    Vannier, JP
    Soria, J
    Soria, C
    CELLULAR SIGNALLING, 2003, 15 (03) : 327 - 338
  • [47] Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells
    Warren Fiskus
    Stacey L. Hembruff
    Rekha Rao
    Priyanka Sharma
    Ramesh Balusu
    Sreedhar Venkannagari
    Jacqueline E. Smith
    Karissa Peth
    Stephen C. Peiper
    Kapil N. Bhalla
    Breast Cancer Research and Treatment, 2012, 135 : 433 - 444
  • [48] Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells
    Fiskus, Warren
    Hembruff, Stacey L.
    Rao, Rekha
    Sharma, Priyanka
    Balusu, Ramesh
    Venkannagari, Sreedhar
    Smith, Jacqueline E.
    Peth, Karissa
    Peiper, Stephen C.
    Bhalla, Kapil N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 433 - 444
  • [49] A novel agent attenuates cardiotoxicity and improves antitumor activity of doxorubicin in breast cancer cells
    Zhang, Ying
    Deng, Hongkuan
    Zhou, Hefeng
    Lu, Yucong
    Shan, Luchen
    Lee, Simon Ming-Yuen
    Cui, Guozhen
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 5913 - 5922
  • [50] Comparison of combination vs. single-agent chemotherapeutic responses in primary cultures of human breast cancer cells.
    Wells, A
    Kornblith, P
    Connell, M
    Ochs, RL
    Burholt, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
12345